Nanoparticle-based tumor theranostics with molecular imaging

Current Pharmaceutical Biotechnology

Volumn 14, Issue 7, 2013, Pages 683-692

  Wang, Lina ^a,b   Wang, Yuebing ^b   Li, Zongjin ^b  

^a INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^b NANKAI UNIVERSITY   (China)

Author keywords

Cancer; Image guided therapy; Molecular imaging; Nanoparticle; Targeted therapy

Indexed keywords

CARBON NANOTUBE; CHITOSAN; GOLD NANOPARTICLE; IMMUNOLIPOSOME; LIPID; LIPOSOME; NANOPARTICLE; NIOSOME; POLYMER; QUANTUM DOT; SILICON DIOXIDE; SILVER NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE;

CANCER THERAPY; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; ECHOGRAPHY; FLUORESCENCE IMAGING; MICELLE; MICROCAPSULE; MOLECULAR IMAGING; MOLECULARLY TARGETED THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOTODYNAMIC THERAPY; POSITRON EMISSION TOMOGRAPHY; REVIEW; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THERAPY EFFECT;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; MOLECULAR IMAGING; NANOPARTICLES; NEOPLASMS; TISSUE DISTRIBUTION;

EID: 84893469278     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201014666131226111248     Document Type: Review

References (104)

1. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. C.A. Cancer J. Clin., 2011, 61, 69-90.
2. Das, M.; Mohanty, C.; Sahoo, S.K. Ligand-based targeted therapy for cancer tissue. Expert Opin. Drug. Deliv., 2009, 6, 285-304.
3. Parveen, S.; Sahoo, S.K. Polymeric nanoparticles for cancer therapy. J. Drug. Target., 2008, 16, 108-123.
4. De Jong, W.H.; Borm, P.J. Drug delivery and nanoparticles: applications and hazards. Int. J. Nanomedicine., 2008, 3, 133-149.
5. Shah, K.; Weissleder, R. Molecular optical imaging: Applications leading to the development of present day therapeutics. NeuroRx., 2005, 2, 215-225.
6. Fass, L. Imaging and cancer: A review. Mol. Oncol., 2008, 2, 115-152.
7. Wang, L.; Su, W.; Liu, Z.; Zhou, M.; Chen, S.; Chen, Y.; Lu, D.; Liu, Y.; Fan, Y.; Zheng, Y.; Han, Z.; Kong, D.; Wu, J.C.; Xiang, R.; Li, Z. CD44 antibody-targeted liposomal nanoparticles for molecular imaging and therapy of hepatocellular carcinoma. Biomaterials, 2012, 33, 5107-5114.
8. Zhou, M.; Wang, L.; Su, W.; Tong, L.; Liu, Y.; Fan, Y.; Luo, N.; Zheng, Y.; Zhao, H.; Xiang, R.; Li, Z. Assessment of therapeutic efficacy of liposomal nanoparticles mediated gene delivery by molecular imaging for cancer therapy. J. Biomed. Nanotechnol., 2012, 8, 742-750.
9. Hong, H.; Gao, T.; Cai, W. Molecular imaging with single-walled carbon nanotubes. Nano Today, 2009, 4, 252-261.
10. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J. Control Release, 2000, 65, 271-284.
11. Bendas, G. Immunoliposomes: A promising approach to targeting cancer therapy. BioDrugs, 2001, 15, 215-224.
12. Singh, R.; Lillard, J.W., Jr. Nanoparticle-based targeted drug delivery. Exp. Mol. Pathol., 2009, 86, 215-223.
13. Maeda, H. The enhanced permeability and retention (EPR) effect in tumor vasculature: The key role of tumor-selective macromolecular drug targeting. Adv. Enzyme. Regul., 2001, 41, 189-207.
14. Yanagie, H.; Fujii, Y.; Takahashi, T.; Tomita, T.; Fukano, Y.; Hasumi, K.; Nariuchi, H.; Yasuda, T.; Sekiguchi, M.; Uchida, H.; et al. Boron neutron capture therapy using 10B entrapped anti-CEA immunoliposome. Hum. Cell, 1989, 2, 290-296.
15. Yanagie, H.; Tomita, T.; Kobayashi, H.; Fujii, Y.; Takahashi, T.; Hasumi, K.; Nariuchi, H.; Sekiguchi, M. Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy model. Br. J. Cancer, 1991, 63, 522-526.
16. Park, J.W.; Hong, K.; Carter, P.; Asgari, H.; Guo, L.Y.; Keller, G. A.; Wirth, C.; Shalaby, R.; Kotts, C.; Wood, W.I.; et al. Development of anti-p185HER2 immunoliposomes for cancer therapy. Proc. Natl. Acad. Sci. U S A., 1995, 92, 1327-1331.
17. Kirpotin, D.; Park, J.W.; Hong, K.; Zalipsky, S.; Li, W.L.; Carter, P.; Benz, C.C.; Papahadjopoulos, D. Sterically stabilized anti-HER2 immunoliposomes: Design and targeting to human breast cancer cells in vitro. Biochemistry, 1997, 36, 66-75.
18. Harata, M.; Soda, Y.; Tani, K.; Ooi, J.; Takizawa, T.; Chen, M.; Bai, Y.; Izawa, K.; Kobayashi, S.; Tomonari, A.; Nagamura, F.; Takahashi, S.; Uchimaru, K.; Iseki, T.; Tsuji, T.; Takahashi, T.A.; Sugita, K.; Nakazawa, S.; Tojo, A.; Maruyama, K.; Asano, S. CD19-targeting liposomes containing imatinib efficiently kill Philadelphia chromosome-positive acute lymphoblastic leukemia cells. Blood, 2004, 104, 1442-1449.
19. Versluis, A.J.; Rensen, P.C.; Rump, E.T.; Van Berkel, T.J.; Bijsterbosch, M.K. Low-density lipoprotein receptor-mediated delivery of a lipophilic daunorubicin derivative to B16 tumours in mice using apolipoprotein E-enriched liposomes. Br. J. Cancer, 1998, 78, 1607-1614.
20. Ruoslahti, E. RGD and other recognition sequences for integrins. Annu. Rev. Cell. Dev. Biol., 1996, 12, 697-715.
21. Schiffelers, R.M.; Koning, G.A.; ten Hagen, T.L.; Fens, M.H.; Schraa, A.J.; Janssen, A.P.; Kok, R.J.; Molema, G.; Storm, G. Antitumor efficacy of tumor vasculature-targeted liposomal doxorubicin. J. Control Release, 2003, 91, 115-122.
22. Murphy, E.A.; Majeti, B.K.; Barnes, L.A.; Makale, M.; Weis, S. M.; Lutu-Fuga, K.; Wrasidlo, W.; Cheresh, D.A. Nanoparticlemediated drug delivery to tumor vasculature suppresses metastasis. Proc. Natl. Acad. Sci. U S A., 2008, 105, 9343-9348.
23. Liu, X.Y.; Ruan, L.M.; Mao, W.W.; Wang, J.Q.; Shen, Y.Q.; Sui, M.H. Preparation of RGD-modified long circulating liposome loading matrine, and its in vitro anti-cancer effects. Int. J. Med. Sci., 2010, 7, 197-208.
24. Banerjee, R.; Tyagi, P.; Li, S.; Huang, L. Anisamide-targeted stealth liposomes: A potent carrier for targeting doxorubicin to human prostate cancer cells. Int. J. Cancer, 2004, 112, 693-700.
25. Goren, D.; Horowitz, A.T.; Tzemach, D.; Tarshish, M.; Zalipsky, S.; Gabizon, A. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump. Clin. Cancer Res., 2000, 6, 1949-1957.
26. Pan, X.; Lee, R.J. Tumour-selective drug delivery via folate receptortargeted liposomes. Expert Opin. Drug. Deliv., 2004, 1, 7-17.
27. Turk, M.J.; Waters, D.J.; Low, P.S. Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma. Cancer Lett., 2004, 213, 165-172.
28. Chen, H.; Ahn, R.; Van den Bossche, J.; Thompson, D.H.; O'Halloran, T.V. Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide. Mol. Cancer. Ther., 2009, 8, 1955-1963.
29. Lee, R.J.; Low, P.S. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro. Biochim. Biophys. Acta., 1995, 1233, 134-144.
30. Kikuchi, A.; Sugaya, S.; Ueda, H.; Tanaka, K.; Aramaki, Y.; Hara, T.; Arima, H.; Tsuchiya, S.; Fuwa, T. Efficient gene transfer to EGF receptor overexpressing cancer cells by means of EGF-labeled cationic liposomes. Biochem. Biophys. Res. Commun., 1996, 227, 666-671.
31. Chen, C.; Peng, J.; Sun, S.R.; Peng, C.W.; Li, Y.; Pang, D.W. Tapping the potential of quantum dots for personalized oncology: Current status and future perspectives. Nanomedicine (Lond), 2012, 7, 411-28.
32. Tada, H.; Higuchi, H.; Wanatabe, T.M.; Ohuchi, N. In vivo realtime tracking of single quantum dots conjugated with monoclonal anti-HER2 antibody in tumors of mice. Cancer Res., 2007, 67, 1138-1144.
33. Nurunnabi, M.; Cho, K.J.; Choi, J.S.; Huh, K.M.; Lee, Y.K. Targeted near-IR QDs-loaded micelles for cancer therapy and imaging. Biomaterials., 2010, 31, 5436-5444.
34. Tang, F.; Li, L.; Chen, D. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery. Adv. Mater., 2012, 24, 1504-1534.
35. Gary-Bobo, M.; Hocine, O.; Brevet, D.; Maynadier, M.; Raehm, L.; Richeter, S.; Charasson, V.; Loock, B.; Morere, A.; Maillard, P.; Garcia, M.; Durand, J.O. Cancer therapy improvement with mesoporous silica nanoparticles combining targeting, drug delivery and PDT. Int. J. Pharm., 2012, 423, 509-515.
36. Li, X.; Xie, Q.R.; Zhang, J.; Xia, W.; Gu, H. The packaging of siRNA within the mesoporous structure of silica nanoparticles. Biomaterials, 2011, 32, 9546-9556.
37. Chen, A.M.; Zhang, M.; Wei, D.; Stueber, D.; Taratula, O.; Minko, T.; He, H. Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. Small, 2009, 5, 2673-2677.
38. Weissig, V.; Whiteman, K.R.; Torchilin, V.P. Accumulation of protein-loaded long-circulating micelles and liposomes in subcutaneous Lewis lung carcinoma in mice. Pharm. Res., 1998, 15, 1552-1556.
39. Torchilin, V.P.; Lukyanov, A.N.; Gao, Z.; Papahadjopoulos-Sternberg, B. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc. Natl. Acad. Sci. USA, 2003, 100, 6039-6044.
40. Perche, F.; Patel, N.R.; Torchilin, V.P. Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model. J. Control. Release., 2012, 164, 95-102.
41. Torchilin, V.P. Targeted polymeric micelles for delivery of poorly soluble drugs. Cell Mol. Life. Sci., 2004, 61, 2549-2559.
42. Zhu, H.; Cao, J.; Cui, S.; Qian, Z.; Gu, Y. Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecinencapsulated folate-modified N-succinyl-N'-octyl chitosan micelles. J. Pharm. Sci., 2013, 102, 1318-1332.
43. Zhang, P.; Hu, L.; Yin, Q.; Feng, L.; Li, Y. Transferrin-modified c[RGDfK]-paclitaxel loaded hybrid micelle for sequential bloodbrain barrier penetration and glioma targeting therapy. Mol. Pharm., 2012, 9, 1590-1598.
44. Cai, W.; Chen, X. Nanoplatforms for Targeted Molecular Imaging in Living Subjects. Small, 2007, 3, 1840-1854.
45. Kunjachan, S.; Gremse, F.; Theek, B.; Koczera, P.; Pola, R.; Pechar, M.; Etrych, T.; Ulbrich, K.; Storm, G.; Kiessling, F.; Lammers, T. Noninvasive optical imaging of nanomedicine biodistribution. ACS Nano, 2013, 7, 252-262.
46. Marti-Bonmati, L.; Sopena, R.; Bartumeus, P.; Sopena, P. Multimodality imaging techniques. Contrast Media Mol. Imaging, 2010, 5, 180-189.
47. Silindir, M.; Ozer, A.Y.; Erdogan, S. The use and importance of liposomes in positron emission tomography. Drug Deliv., 2012, 19, 68-80.
48. Mudd, S.R.; Trubetskoy, V.S.; Blokhin, A.V.; Weichert, J.P.; Wolff, J.A. Hybrid PET/CT for noninvasive pharmacokinetic evaluation of dynamic PolyConjugates, a synthetic siRNA delivery system. Bioconjug. Chem., 2010, 21, 1183-1189.
49. Townsend, D.W. Dual-modality imaging: combining anatomy and function. J. Nucl. Med., 2008, 49, 938-955.
50. Carrera, D.; Bajen, M.T.; Mora, J.; Ricart, Y.; Benitez, A.; Ferran, N.; Guirao, S.; Fernandez-Sevilla, A.; Martin-Comin, J. [Clinical utility of fused 67Ga SPECT/CT scan images in patients with lymphoma]. Rev. Esp. Med. Nucl., 2006, 25, 3-9.
51. Husarik, D.B.; Steinert, H.C. Single-photon emission computed tomography/computed tomographyfor sentinel node mapping in breast cancer. Semin. Nucl. Med., 2007, 37, 29-33.
52. Chrastina, A.; Schnitzer, J.E. Iodine-125 radiolabeling of silver nanoparticles for in vivo SPECT imaging. Int. J. Nanomedicine, 2010, 5, 653-659.
53. Harrington, K.J.; Mohammadtaghi, S.; Uster, P.S.; Glass, D.; Peters, A.M.; Vile, R.G.; Stewart, J.S. Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. Clin. Cancer Res., 2001, 7, 243-254.
54. Lammers, T.; Kuhnlein, R.; Kissel, M.; Subr, V.; Etrych, T.; Pola, R.; Pechar, M.; Ulbrich, K.; Storm, G.; Huber, P.; Peschke, P. Effect of physicochemical modification on the biodistribution and tumor accumulation of HPMA copolymers. J. Control Release, 2005, 110, 103-118.
55. Hoffmann, S.; Vystrcilova, L.; Ulbrich, K.; Etrych, T.; Caysa, H.; Mueller, T.; Mader, K. Dual fluorescent HPMA copolymers for passive tumor targeting with pH-sensitive drug release: synthesis and characterization of distribution and tumor accumulation in mice by noninvasive multispectral optical imaging. Biomacromolecules, 2012, 13, 652-663.
56. Xie, H.; Goins, B.; Bao, A.; Wang, Z.J.; Phillips, W.T. Effect of intratumoral administration on biodistribution of 64Cu-labeled nanoshells. Int. J. Nanomedicine, 2012, 7, 2227-38.
57. Hebert, E.M.; Debouttiere, P.J.; Lepage, M.; Sanche, L.; Hunting, D.J. Preferential tumour accumulation of gold nanoparticles, visualised by Magnetic Resonance Imaging: Radiosensitisation studies in vivo and in vitro. Int. J. Radiat. Biol., 2010, 86, 692-700.
58. van Dongen, G. A.; Visser, G. W.; Lub-de Hooge, M. N.; de Vries, E. G.; Perk, L. R. Immuno-PET: A navigator in monoclonal antibody development and applications. Oncologist, 2007, 12, 1379-1389.
59. Torres, E.; Mainini, F.; Napolitano, R.; Fedeli, F.; Cavalli, R.; Aime, S.; Terreno, E. Improved paramagnetic liposomes for MRI visualization of pH triggered release. J. Control Release, 2011, 154, 196-202.
60. Ponce, A.M.; Viglianti, B.L.; Yu, D.; Yarmolenko, P.S.; Michelich, C.R.; Woo, J.; Bally, M.B.; Dewhirst, M.W. Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects. J. Natl. Cancer. Inst., 2007, 99, 53-63.
61. Xie, M.; Shi, H.; Li, Z.; Shen, H.; Ma, K.; Li, B.; Shen, S.; Jin, Y. A multifunctional mesoporous silica nanocomposite for targeted delivery, controlled release of doxorubicin and bioimaging. Colloids Surf. B. Biointerfaces, 2013, 110C, 138-147.
62. Viglianti, B.L.; Ponce, A.M.; Michelich, C.R.; Yu, D.; Abraham, S. A.; Sanders, L.; Yarmolenko, P.S.; Schroeder, T.; MacFall, J.R.; Barboriak, D.P.; Colvin, O.M.; Bally, M.B.; Dewhirst, M.W. Chemodosimetry of in vivo tumor liposomal drug concentration using MRI. Magn. Reson. Med., 2006, 56, 1011-1018.
63. Song, J.; Fang, Z.; Wang, C.; Zhou, J.; Duan, B.; Pu, L.; Duan, H. Photolabile plasmonic vesicles assembled from amphiphilic gold nanoparticles for remote-controlled traceable drug delivery. Nanoscale, 2013, 5, 5816-5824.
64. Sun, J.T.; Yu, Z.Q.; Hong, C.Y.; Pan, C.Y. Biocompatible zwitterionic sulfobetaine copolymer-coated mesoporous silica nanoparticles for temperature-responsive drug release. Macromol. Rapid. Commun., 2012, 33, 811-818.
65. Li, Z.; Han, Z.; Wu, J.C. Transplantation of human embryonic stem cell-derived endothelial cells for vascular diseases. J. Cell. Biochem., 2009, 106, 194-199.
66. Li, Z.; Suzuki, Y.; Huang, M.; Cao, F.; Xie, X.; Connolly, A.J.; Yang, P.C.; Wu, J.C. Comparison of reporter gene and iron particle labeling for tracking fate of human embryonic stem cells and differentiated endothelial cells in living subjects. Stem Cells, 2008, 26, 864-873.
67. Lammers, T.; Kiessling, F.; Hennink, W. E.; Storm, G. Nanotheranostics and image-guided drug delivery: Current concepts and future directions. Mol. Pharm., 2010, 7, 1899-1912.
68. Lammers, T.; Subr, V.; Peschke, P.; Kuhnlein, R.; Hennink, W.E.; Ulbrich, K.; Kiessling, F.; Heilmann, M.; Debus, J.; Huber, P.E.; Storm, G. Image-guided and passively tumour-targeted polymeric nanomedicines for radiochemotherapy. Br. J. Cancer, 2008, 99, 900-910.
69. Rodriguez-Porcel, M.; Cai, W.; Gheysens, O.; Willmann, J.K.; Chen, K.; Wang, H.; Chen, I.Y.; He, L.; Wu, J. C.; Li, Z.B.; Mohamedali, K.A.; Kim, S.; Rosenblum, M.G.; Chen, X.; Gambhir, S.S. Imaging of VEGF receptor in a rat myocardial infarction model using PET. J. Nucl. Med., 2008, 49, 667-73.
70. Sadeghi, M.M.; Bender, J.R. Activated alphavbeta3 integrin targeting in injury-induced vascular remodeling. Trends Cardiovasc. Med., 2007, 17, 5-10.
71. Kalinowski, L.; Dobrucki, L.W.; Meoli, D.F.; Dione, D.P.; Sadeghi, M.M.; Madri, J.A.; Sinusas, A.J. Targeted imaging of hypoxia-induced integrin activation in myocardium early after infarction. J. Appl. Physiol., 2008, 104, 1504-1512.
72. Agostinis, P.; Berg, K.; Cengel, K.A.; Foster, T.H.; Girotti, A.W.; Gollnick, S.O.; Hahn, S.M.; Hamblin, M.R.; Juzeniene, A.; Kessel, D.; Korbelik, M.; Moan, J.; Mroz, P.; Nowis, D.; Piette, J.; Wilson, B.C.; Golab, J. Photodynamic therapy of cancer: an update. C.A. Cancer J. Clin., 2011, 61, 250-281.
73. Dolmans, D.E.; Fukumura, D.; Jain, R.K. Photodynamic therapy for cancer. Nat. Rev. Cancer, 2003, 3, 380-387.
74. Koo, Y.E.; Fan, W.; Hah, H.; Xu, H.; Orringer, D.; Ross, B.; Rehemtulla, A.; Philbert, M.A.; Kopelman, R. Photonic explorers based on multifunctional nanoplatforms for biosensing and photodynamic therapy. Appl. Opt., 2007, 46, 1924-1930.
75. Wang, Y.; Wang, H.; Liu, D.; Song, S.; Wang, X.; Zhang, H. Graphene oxide covalently grafted upconversion nanoparticles for combined NIR mediated imaging and photothermal/photodynamic cancer therapy. Biomaterials, 2013, 34, 7715-7724.
76. Chen, R.; Wang, X.; Yao, X.; Zheng, X.; Wang, J.; Jiang, X. Near-IR-triggered photothermal / photodynamic dual-modality therapy system via chitosan hybrid nanospheres. Biomaterials, 2013, 34, 8314-8322.
77. Wang, Y.-G.; Kim, H.; Mun, S.; Kim, D.; Choi, Y. Indocyanine green-loaded perfluorocarbon nanoemulsions for bimodal 19 Fmagnetic resonance / nearinfrared fluorescence imaging and subsequent phototherapy. Medicine, 2013, 3, 132-140.
78. Jang, B.; Park, J.-Y.; Tung, C.-H.; Kim, I.-H.; Choi, Y. Gold Nanorod-photosensitizer complex for near-infrared fluorescence imaging and photodynamic/photothermal therapy in vivo. ACS Nano, 2011, 5, 1086-1094.
79. Lin, J.; Wang, S.; Huang, P.; Wang, Z.; Chen, S.; Niu, G.; Li, W.; Al, L.I.N.E.T. Photosensitizer-loaded gold vesicles with strong plasmonic coupling effect for imaging-guided photothermal / photodynamic therapy. ACS Nano, 2013, 7, 5320-5329.
80. Lee, P.C.; Chiou, Y.C.; Wong, J.M.; Peng, C.L.; Shieh, M.J. Targeting colorectal cancer cells with single-walled carbon nanotubes conjugated to anticancer agent SN-38 and EGFR antibody. Biomaterials, 2013, 34, 8756-8765.
81. Nima, Z.A.; Mahmood, M.W.; Karmakar, A.; Mustafa, T.; Bourdo, S.; Xu, Y.; Biris, A.S. Single-walled carbon nanotubes as specific targeting and Raman spectroscopic agents for detection and discrimination of single human breast cancer cells. J. Biomed. Opt., 2013, 18, 55003.
82. Jeyamohan, P.; Hasumura, T.; Nagaoka, Y.; Yoshida, Y.; Maekawa, T.; Kumar, D.S. Accelerated killing of cancer cells using a multifunctional single-walled carbon nanotube-based system for targeted drug delivery in combination with photothermal therapy. Int. J. Nanomedicine, 2013, 8, 2653-2667.
83. Chen, C.; Zhang, H.; Hou, L.; Shi, J.; Wang, L.; Zhang, C.; Zhang, M.; Shi, X.; Li, H.; Zhang, Z. Single-walled carbon nanotubes mediated neovascularity targeted antitumor drug delivery system. J. Pharm. Pharm. Sci., 2013, 16, 40-51.
84. Wang, Y.; Liu, P.; Du, J.; Sun, Y.; Li, F.; Duan, Y. Targeted siRNA delivery by anti-HER2 antibody-modified nanoparticles of mPEG-chitosan diblock copolymer. J. Biomater. Sci. Polym. Ed., 2013, 24, 1219-1232.
85. Bu, L.; Gan, L.C.; Guo, X.Q.; Chen, F.Z.; Song, Q.; Qi, Z.; Gou, X.J.; Hou, S.X.; Yao, Q. Trans-resveratrol loaded chitosan nanoparticles modified with biotin and avidin to target hepatic carcinoma. Int. J. Pharm., 2013, 452, 355-362.
86. Xu, S.; Xu, Q.; Zhou, J.; Wang, J.; Zhang, N.; Zhang, L. Preparation and characterization of folate-chitosan-gemcitabine core-shell nanoparticles for potential tumor-targeted drug delivery. J. Nanosci. Nanotechnol., 2013, 13, 129-138.
87. Karra, N.; Nassar, T.; Ripin, A.N.; Schwob, O.; Borlak, J.; Benita, S. Antibody conjugated plga nanoparticles for targeted delivery of paclitaxel palmitate: Efficacy and biofate in a lung cancer mouse model. Small, 2013, 9(24), 4221-4236
88. Mitra, M.; Misra, R.; Harilal, A.; Sahoo, S.K.; Krishnakumar, S. Enhanced in vitro antiproliferative effects of EpCAM antibodyfunctionalized paclitaxel-loaded PLGA nanoparticles in retinoblastoma cells. Mol. Vis., 2011, 17, 2724-2737.
89. Vangara, K.K.; Liu, J.L.; Palakurthi, S. Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer. Anticancer. Res., 2013, 33, 2425-2434.
90. Chen, C.; Mei, H.; Shi, W.; Deng, J.; Zhang, B.; Guo, T.; Wang, H.; Hu, Y. EGFP-EGF1-conjugated PLGA nanoparticles for targeted delivery of siRNA into injured brain microvascular endothelial cells for efficient RNA interference. PLoS One, 2013, 8, e60860.
91. Liu, P.; Wang, H.; Wang, Q.; Sun, Y.; Shen, M.; Zhu, M.; Wan, Z.; Duan, Y. cRGD conjugated mPEG-PLGA-PLL nanoparticles for SGC-7901 gastric cancer cells-targeted Delivery of fluorouracil. J. Nanosci. Nanotechnol., 2012, 12, 4467-4471.
92. Kim, C.K.; Duong, H.D.; Rhee, J.I. Sequential injection immunoassay for human bone morphogenic protein-7 using an immunoreactor immobilized with anti-human bone morphogenic protein-7 antibody-CdSe/ZnS quantum dot conjugates. Anal. Chim. Acta, 2013, 786, 78-84.
93. Cai, W.; Shin, D.W.; Chen, K.; Gheysens, O.; Cao, Q.; Wang, S. X.; Gambhir, S.S.; Chen, X. Peptide-labeled near-infrared quantum dots for imaging tumor vasculature in living subjects. Nano Lett., 2006, 6, 669-676.
94. Zhang, B.; Wang, X.; Liu, F.; Cheng, Y.; Shi, D. Effective reduction of nonspecific binding by surface engineering of quantum dots with bovine serum albumin for cell-targeted imaging. Langmuir, 2012, 28, 16605-13.
95. Ceresa, C.; Nicolini, G.; Rigolio, R.; Bossi, M.; Pasqua, L.; Cavaletti, G. Functionalized mesoporous silica nanoparticles: a possible strategy to target cancer cells reducing peripheral nervous system uptake. Curr. Med. Chem., 2013, 20, 2589-2600.
96. Pan, L.; Liu, J.; He, Q.; Wang, L.; Shi, J. Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles. Biomaterials, 2013, 34, 2719-2730.
97. Chen, Z.; Li, Z.; Lin, Y.; Yin, M.; Ren, J.; Qu, X. Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery. Chemistry, 2013, 19, 1778-1783.
98. Kleespies, A.; Jauch, K.W.; Bruns, C.J. Tyrosine kinase inhibitors and gemcitabine: New treatment options in pancreatic cancer? Drug Resist. Updat., 2006, 9, 1-18.
99. Sun, X.; Zhang, G.; Patel, D.; Stephens, D.; Gobin, A.M. Targeted cancer therapy by immunoconjugated gold-gold sulfide nanoparticles using Protein G as a cofactor. Ann. Biomed. Eng., 2012, 40, 2131-2139.
100. Kumar, A.; Ma, H.; Zhang, X.; Huang, K.; Jin, S.; Liu, J.; Wei, T.; Cao, W.; Zou, G.; Liang, X.J. Gold nanoparticles functionalized with therapeutic and targeted peptides for cancer treatment. Biomaterials, 2012, 33, 1180-1189.
101. Wang, Y.; Newell, B.B.; Irudayaraj, J. Folic acid protected silver nanocarriers for targeted drug delivery. J. Biomed. Nanotechnol., 2012, 8, 751-759.
102. Locatelli, E.; Broggi, F.; Ponti, J.; Marmorato, P.; Franchini, F.; Lena, S.; Franchini, M.C. Lipophilic silver nanoparticles and their polymeric entrapment into targeted-PEG-based micelles for the treatment of glioblastoma. Adv. Healthc. Mater., 2012, 1, 342-347.
103. Li, J.; Zheng, L.; Cai, H.; Sun, W.; Shen, M.; Zhang, G.; Shi, X. Polyethyleneimine-mediated synthesis of folic acid-targeted iron oxide nanoparticles for in vivo tumor MR imaging. Biomaterials, 2013, 34, 8382-8392.
104. Cowger, T.; Xie, J. Polyaspartic acid coated iron oxide nanoprobes for PET/MRI imaging methods. Mol. Biol., 2013, 1025, 225-235.